Marco Metra is an Associate Professor of cardiology at the University of Brescia, Italy. He received his Medical degree in 1981. He was a Research Associate at the Committee on Clinical Pharmacology of the University of Chicago, Illinois, (Director, Professor Leon I. Goldberg) United States, in 1985, returning to the University of Brescia the following year as a Research Associate. His research is focused on heart failure, in particular the functional evaluation of the patient with heart failure, the role of sympathetic activity and ß-blocker therapy, and the assessment and treatment of acute heart failure. Professor Metra is the Principal Investigator and Member of the Executive Committee of the PROTECT and REACH-UP trials, assessing the effects of rolofylline in patients with acute heart failure, the Cochairman of the RELAX-HF trial, and a Member of the executive committee or steering committee of other trials, including ASCEND–HF and SHIFT trials. In addition, he is a Board Member of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) from 2001 to 2008; Professor Metra served as Secretary of the Executive Board between 2004 and 2006. He has also been a Member of the ESC’s Committee for Practice Guidelines (years 2004–2006), and has been a Cochair with Professor Dickstein of the 2008 meeting of the HFA of ESC, held in Milan in June 14–17, 2008. Professor Metra is the author of more than 200 articles in peer-reviewed journals (total impact factor, 578) as well as of numerous other publications and book chapters.
Biography Updated on 2 August 2009